The global antisense and RNAi therapeutics market reached USD 5.10 Billion in 2024 and is projected to grow at a CAGR of 18.70% to USD 28.32 Billion by 2034. Growth is driven by rising investments in genetic research, expanding applications in rare and chronic diseases, and increasing demand for targeted gene-silencing therapies. https://www.expertmarketresearch.com/reports/antisense-and-rnai-therapeutics-market